Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis.

Authors:
Harrington C; Krishnan S; Mack CL; Cravedi P; Assis DN and 1 more

Journal:
Hepatology

Publication Year: 2022

DOI:
10.1002/hep.32591

PMCID:
PMC9796683

PMID:
35611859

View on PubMed View on PMC View Publisher

Journal Information

Full Title: Hepatology

Abbreviation: Hepatology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal

View All Papers from This Journal

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"CONFLICTs OF INTEREST Dr. Levitsky consults and received grants from Transplant Genomics Inc. He received grants from Novartis."

Funding Disclosure

Evidence found in paper:

"FUNDING INFORMATION None."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025

Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis.

Journal Information

Publication Details

Related Papers from Same Journal

A global action agenda for turning the tide on fatty liver disease.

c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis.

Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex wi…

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hep…

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression.

Transparency Score

Transparency Indicators

Core Indicators

Additional Indicators

Assessment Info